Pablo Legorreta (investor - Angel Investor)
See something wrong or missing? Let us know
Pablo Legorreta is a former Wall Street investment banker from a prominent Mexican family who keeps a low profile. He is founder & CEO of Royalty Pharma, the industry leader in acquiring revenue-producing intellectual property, with over $15 billion in royalty assets either indirectly, when it acquires existing royalty interests from the original innovators (academic institutions, research hospitals, foundations and inventors) or directly, when it partners with life sciences companies to co-develop and co-fund products in late-stage human clinical trials.
Average round investment:67M USD
Average number per year:1.0
Distribution:
2018 (1)
Portfolio companies:
ITBMed

Mostly invests in:
Sweden (1)
Biotech (1)

1 tracked investments in:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Investors with similar profile to Pablo Legorreta
Name | Criteria | |
---|---|---|
![]() |
General Atlantic
71%
|
|
![]() |
Sampo Group
70%
|
|
![]() |
Mubadala Capital
68%
|
|
![]() |
Venrock Healthcare Capital Partners
68%
|
|
![]() |
GT Healthcare Capital
68%
|
|
![]() |
Foresite Capital
68%
|
|
![]() |
Viking Global Investors
68%
|
|
![]() |
Evotec AG
68%
|
|
![]() |
Cormorant Asset Management
68%
|
|
![]() |
venBio Partners
68%
|
|